Avacta Life Sciences unveils custom seven week Affimer service to revolutionise life sciences

08:24 EDT 10 Aug 2015 | Scott PR

Avacta Life Sciences, the global provider of high quality reagents for life sciences, has launched a ground breaking new website for it’s Affimer technology.

Affimers are a new alternative to antibodies and aptamers. Based on a small protein scaffold, they can be engineered to bind with high specificity and affinity to a wide range of protein targets. Affimers can be used for a wide range of applications in diagnostics, drug / biomarker discovery, biotech research & development and in developing therapeutics.

To provide a world-class user experience for customers, Avacta’s new website has been responsively designed for optimised viewing on desktop, mobile and tablets. The sleek aesthetics draw on Avacta’s branding and ensures that the look and feel of the website reflect the high quality, cutting edge nature of Avacta’s Affimer products.

Michael Vinegrad, Head of Marketing at Avacta said: “We’re delighted to now be able to offer our catalogue reagents for sale via a vastly improved, secure ecommerce store. We’re also delighted that the website also functions as a shop window for Affimer technology and our 7 week custom Affimer service. The time taken to generate antibodies can be a considerable issue for life scientists. Our 7 week service could be a real game changer. “

Find out more at


More From BioPortfolio on "Avacta Life Sciences unveils custom seven week Affimer service to revolutionise life sciences"

Quick Search


Relevant Topics

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...